Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Radius raises $57.5mm in Series C round

Executive Summary

Radius Health (developing therapeutics for women's health, osteoporosis, and inflammation) has raised $29mm in the first closing of its Series C financing round (what the company calls its "second institutional financing"). It plans to bring in an additional $28.5mm in a second closing; at that point, Radius will have raised $81.5mm since its 2003 inception. Existing backer MPM Capital and new investor the Wellcome Trust co-led the first tranche, and were joined by HealthCare Ventures and Oxford Bioscience Partners (both existing investors) and additional newcomers BB Biotech and the Scottish Widows Investment Partnership.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies